XHKG2393
Market cap18mUSD
Dec 23, Last price
0.06HKD
1D
-7.69%
1Q
17.65%
Jan 2017
-98.40%
IPO
-86.52%
Name
Yestar Healthcare Holdings Co Ltd
Chart & Performance
Profile
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain activities; and provision of freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,912,733 -32.17% | 4,293,982 -12.91% | 4,930,692 20.06% | |||||||
Cost of revenue | 2,780,529 | 4,250,643 | 4,740,247 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 132,204 | 43,339 | 190,445 | |||||||
NOPBT Margin | 4.54% | 1.01% | 3.86% | |||||||
Operating Taxes | 39,562 | 86,748 | 47,263 | |||||||
Tax Rate | 29.92% | 200.16% | 24.82% | |||||||
NOPAT | 92,642 | (43,409) | 143,182 | |||||||
Net income | (13,888) -98.60% | (992,232) -29,923.62% | 3,327 -100.56% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (22,397) | |||||||||
BB yield | 0.83% | |||||||||
Debt | ||||||||||
Debt current | 1,598,796 | 1,778,173 | 542,270 | |||||||
Long-term debt | 86,356 | 327,430 | 1,331,609 | |||||||
Deferred revenue | 6,944 | 7,133 | 7,322 | |||||||
Other long-term liabilities | (234,571) | |||||||||
Net debt | 1,433,590 | 1,654,485 | 1,108,871 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 387,669 | (91,727) | 715,221 | |||||||
CAPEX | (93,332) | (23,852) | (49,674) | |||||||
Cash from investing activities | (89,819) | (18,722) | (47,675) | |||||||
Cash from financing activities | (234,371) | (180,856) | (654,199) | |||||||
FCF | 34,049 | 79,496 | 233,031 | |||||||
Balance | ||||||||||
Cash | 251,562 | 418,146 | 751,767 | |||||||
Long term investments | 32,972 | 13,241 | ||||||||
Excess cash | 105,925 | 236,419 | 518,473 | |||||||
Stockholders' equity | (1,490,784) | (203,031) | 799,000 | |||||||
Invested Capital | 2,727,683 | 1,612,943 | 2,012,394 | |||||||
ROIC | 4.27% | 6.89% | ||||||||
ROCE | 10.14% | 2.90% | 6.90% | |||||||
EV | ||||||||||
Common stock shares outstanding | 2,331,590 | 2,331,590 | 2,346,582 | |||||||
Price | 0.05 -86.36% | 0.33 -71.30% | 1.15 -3.36% | |||||||
Market cap | 104,922 -86.36% | 769,425 -71.49% | 2,698,569 -3.98% | |||||||
EV | 1,597,571 | 3,480,801 | 4,702,268 | |||||||
EBITDA | 303,260 | 273,922 | 422,914 | |||||||
EV/EBITDA | 5.27 | 12.71 | 11.12 | |||||||
Interest | 164,709 | 298,575 | 127,788 | |||||||
Interest/NOPBT | 124.59% | 688.93% | 67.10% |